Share

Adeptus Health (NYSE:ADPT) Receives Buy Rating From Jefferies & Co Analysts

A current consensus EPS projection for next fiscal year is observed at $-5.80 and one month ago consensus EPS forecast was at $-5.80.

Advertisement

The company has a P/E ratio of 5.44.

A number of other analysts have also recently weighed in on the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the stock.

Over the last twelve months Adeptus Health’s stock price has decreased by -66.49% from 106.52 to 35.7. Coefficient Variance is noted at 10.1.

A significant surprise factor often results in stock volatility and sharp price movements following the earnings announcement.

Different Analysts projected the EPS Estimate for Next Quarter. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by $0.03. Maximum EPS estimate that expected in next quarter is noted at $1.09 and minimum forecasted EPS is calculated at $0.89.

U.S. based company, Adeptus Health Inc.’s (ADPT)’s latest closing price was -33.71% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -24.56% and -17.10% compared with the 20 Day Moving Average.

Molina Healthcare Inc (NYSE:MOH) stock dropped +3.53% or +1.94 points. Total 893.63 thousand shares changed on hands and it kept the average volume of 905.86 thousand shares. The previous close of the stock was called at $55.00.

The company has encountered a twelve month cheapest price of $ 44.50 and hit a twelve month expensive price of $ 81.95. Texas Permanent School Fund now owns 9,584 shares of the company’s stock valued at $532,000 after buying an additional 4,645 shares in the last quarter. The PEG ratio is used to determine a stock’s value while taking the company’s earnings growth into account, and is considered to provide a more complete picture than the P/E ratio. In terms of sales expectations, the surprise factor in per share dollar terms was $7.297 away from what analysts had projected for the quarter, or a difference of 7.857%. The highest estimate stands at $103 while the lowest target is $67. The Corporation has a Mean Rating of 1.95 based on the Reuters Analysts consensus issuing ratings. Coefficient Variance is noted at 12.56.

Advertisement

During last 3 month it remained at -37.52%. Oberweis Asset Management Inc. now owns 130,372 shares of the company’s stock valued at $7,108,000 after buying an additional 35,790 shares in the last quarter.

Adeptus Health